Abstract
Ebola virus (EBOV) continues to pose a significant threat to human health, as evidenced by the 2013-2016 epidemic in West Africa and the ongoing outbreak in the Democratic Republic of the Congo. EBOV causes hemorrhagic fever, organ damage, and shock culminating in death, with case fatality rates as high as 90%. This high lethality combined with the paucity of licensed medical countermeasures makes EBOV a critical human pathogen. Although EBOV infection results in significant damage to the liver and the adrenal glands, little is known about the molecular signatures of injury in these organs. Moreover, while changes in peripheral blood cells are becoming increasingly understood, the host responses within organs and lymphoid tissues remain poorly characterized. To address this knowledge gap, we tracked longitudinal transcriptional changes in tissues collected from EBOV-Makona-infected cynomolgus macaques. Following infection, both liver and adrenal glands exhibited significant and early downregulation of genes involved in metabolism, coagulation, hormone synthesis, and angiogenesis; upregulated genes were associated with inflammation. Analysis of lymphoid tissues showed early upregulation of genes that play a role in innate immunity and inflammation and downregulation of genes associated with cell cycle and adaptive immunity. Moreover, transient activation of innate immune responses and downregulation of humoral immune responses in lymphoid tissues were confirmed with flow cytometry. Together, these data suggest that the liver, adrenal gland, and lymphatic organs are important sites of EBOV infection and that dysregulating the function of these vital organs contributes to the development of Ebola virus disease.
| Original language | English |
|---|---|
| Article number | e00250-20 |
| Journal | Journal of Virology |
| Volume | 94 |
| Issue number | 11 |
| DOIs | |
| State | Published - Jun 1 2020 |
Bibliographical note
Publisher Copyright:Copyright © 2020 American Society for Microbiology. All Rights Reserved.
Funding
This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, and NIH grant U19A109945. Preparation of the Ebola virus seed stock was supported by NIAID/NIH grant U19AI109711. Operational support of the Galveston National Laboratory was provided by NIAID/NIH grant UC7AI094660.
| Funders | Funder number |
|---|---|
| National Institutes of Health (NIH) | U19A109945 |
| National Institute of Allergy and Infectious Diseases | UC7AI094660, U19AI109711 |
ASJC Scopus subject areas
- Microbiology
- Immunology
- Insect Science
- Virology